Loargys 5 MG per 1 ML Injection
- RxCUI
- 2738662
- RxNorm name
- Loargys 5 MG per 1 ML Injection
- Display name
- Loargys 5 MG per 1 ML Injection
- Full name
- Loargys 5 MG per 1 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761211 | Loargys | pegzilarginase-nbln | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loargys | PEGZILARGINASE-NBLN | Immedica Pharma US Inc. | d5ceabf2-43a0-4746-9371-d98a39cf6cfc | 2026-02-23 | Boxed warning, Warnings, Adverse reactions | 2738662 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d5ceabf2-43a0-4746-9371-d98a39cf6cfc | Loargys 5 MG per 1 ML Injection | SY | 1 | These highlights do not include all the information needed to use LOARGYS safely and effectively. See full prescribing information for LOARGYS . LOARGYS (pegzilarginase-nbln) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2026 | 20260223 |
| d5ceabf2-43a0-4746-9371-d98a39cf6cfc | Loargys 5 MG in 1 ML Injection | PSN | 1 | These highlights do not include all the information needed to use LOARGYS safely and effectively. See full prescribing information for LOARGYS . LOARGYS (pegzilarginase-nbln) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2026 | 20260223 |
| d5ceabf2-43a0-4746-9371-d98a39cf6cfc | 1 ML pegzilarginase-nbln 5 MG/ML Injection [Loargys] | SBD | 1 | These highlights do not include all the information needed to use LOARGYS safely and effectively. See full prescribing information for LOARGYS . LOARGYS (pegzilarginase-nbln) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2026 | 20260223 |
| d5ceabf2-43a0-4746-9371-d98a39cf6cfc | Loargys 5 MG/ML per 1 ML Injection | SY | 1 | These highlights do not include all the information needed to use LOARGYS safely and effectively. See full prescribing information for LOARGYS . LOARGYS (pegzilarginase-nbln) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2026 | 20260223 |